D Marks1, M Thorogood, J M Farrer, S E Humphries. 1. Public and Environmental Health Research Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT.
Abstract
BACKGROUND: Screening for familial hypercholesterolaemia (FH) through family tracing of relatives is cost-effective, but access to the index patient through specialist lipid clinics is a determinant of the programme's success. This paper reports on numbers of FH patients and on specialist lipid clinic provision in the United Kingdom. RESULTS: One hundred and forty-four clinics provide specialist lipid services. Over 20 per cent of clinics do not employ a nurse and 64 per cent employ only one doctor. Two thirds treat children. Thirty-four clinics (24 per cent) have computerized records, 58 plan to and 66 clinics were unable to estimate FH numbers. Data from the responding clinics identified 4665 'definite' and 6024 'probable' FH cases. By extrapolation, we estimate there are 19 794 FH patients treated in specialist centres, 17 per cent of the predicted number. COMMENT: Specialist lipid clinic provision is patchy. Less than 10 per cent of the predicted FH patients in the UK are recorded on computerized databases limiting implementation of cascade testing. Substantial investment in the infrastructure of specialist lipid clinics is needed.
BACKGROUND: Screening for familial hypercholesterolaemia (FH) through family tracing of relatives is cost-effective, but access to the index patient through specialist lipid clinics is a determinant of the programme's success. This paper reports on numbers of FHpatients and on specialist lipid clinic provision in the United Kingdom. RESULTS: One hundred and forty-four clinics provide specialist lipid services. Over 20 per cent of clinics do not employ a nurse and 64 per cent employ only one doctor. Two thirds treat children. Thirty-four clinics (24 per cent) have computerized records, 58 plan to and 66 clinics were unable to estimate FH numbers. Data from the responding clinics identified 4665 'definite' and 6024 'probable' FH cases. By extrapolation, we estimate there are 19 794 FHpatients treated in specialist centres, 17 per cent of the predicted number. COMMENT: Specialist lipid clinic provision is patchy. Less than 10 per cent of the predicted FHpatients in the UK are recorded on computerized databases limiting implementation of cascade testing. Substantial investment in the infrastructure of specialist lipid clinics is needed.
Authors: Nina Hallowell; Nick Jenkins; Margaret Douglas; Simon Walker; Robert Finnie; Mary Porteous; Julia Lawton Journal: J Community Genet Date: 2011-09-02
Authors: Steve E Humphries; Treena Cranston; Marcus Allen; Helen Middleton-Price; Maryam C Fernandez; Victoria Senior; Emma Hawe; Andrew Iversen; Richard Wray; Martin A Crook; Anthony S Wierzbicki Journal: J Mol Med (Berl) Date: 2005-12-31 Impact factor: 4.599
Authors: Sarah J Hardcastle; Ellen Legge; Chris S Laundy; Sarah J Egan; Rosemary French; Gerald F Watts; Martin S Hagger Journal: Int J Behav Med Date: 2015-02
Authors: Mahtab Sharifi; Małgorzata Walus-Miarka; Barbara Idzior-Waluś; Maciej T Malecki; Marek Sanak; Ros Whittall; Ka Wah Li; Marta Futema; Steve E Humphries Journal: Metabolism Date: 2015-11-10 Impact factor: 8.694
Authors: Sarah Leigh; Marta Futema; Ros Whittall; Alison Taylor-Beadling; Maggie Williams; Johan T den Dunnen; Steve E Humphries Journal: J Med Genet Date: 2016-11-07 Impact factor: 6.318
Authors: Mahtab Sharifi; Elizabeth Higginson; Sven Bos; Angela Gallivan; Darren Harvey; Ka Wah Li; Amali Abeysekera; Angela Haddon; Helen Ashby; Kate E Shipman; Jackie A Cooper; Marta Futema; Jeanine E Roeters van Lennep; Eric J G Sijbrands; Mourad Labib; Devaki Nair; Steve E Humphries Journal: Atherosclerosis Date: 2017-05-13 Impact factor: 5.162
Authors: Karen Forrest Keenan; Robert M Finnie; William G Simpson; Lorna McKee; John Dean; Zosia Miedzybrodzka Journal: J Community Genet Date: 2018-06-14
Authors: Marta Futema; Ros A Whittall; Amy Kiley; Louisa K Steel; Jackie A Cooper; Ebele Badmus; Sarah E Leigh; Fredrik Karpe; H Andrew W Neil; Steve E Humphries Journal: Atherosclerosis Date: 2013-04-18 Impact factor: 5.162